Canaan Xi L.p. - Net Worth and Insider Trading
Canaan Xi L.p. Net Worth
The estimated net worth of Canaan Xi L.p. is at least $116 Million dollars as of 2024-05-14. Canaan Xi L.p. is the 10% Owner of Day One Biopharmaceuticals Inc and owns about 6,964,301 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $116 Million. Details can be seen in Canaan Xi L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Canaan Xi L.p. has not made any transactions after 2022-09-21 and currently still holds the listed stock(s).
Transaction Summary of Canaan Xi L.p.
Canaan Xi L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Canaan Xi L.p. owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Tyra Biosciences Inc (TYRA) .
Click here to see the complete history of Canaan Xi L.p.’s form 4 insider trades.
Insider Ownership Summary of Canaan Xi L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2022-09-21 | 10 percent owner |
| TYRA | Tyra Biosciences Inc | 2021-09-14 | 10 percent owner |
Canaan Xi L.p. Latest Holdings Summary
Canaan Xi L.p. currently owns a total of 1 stock. Canaan Xi L.p. owns 6,964,301 shares of Day One Biopharmaceuticals Inc (DAWN) as of September 21, 2022, with a value of $116 Million.
Latest Holdings of Canaan Xi L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2022-09-21 | 6,964,301 | 16.62 | 115,746,683 |
Holding Weightings of Canaan Xi L.p.
Canaan Xi L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Canaan Xi L.p. has made a total of 3 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 613,603 shares on September 21, 2022, which brought Canaan Xi L.p. around $11 Million.
Insider Trading History of Canaan Xi L.p.
- 1
Canaan Xi L.p. Trading Performance
Canaan Xi L.p. Ownership Network
Canaan Xi L.p. Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Canaan Xi L.p. is the 10 percent owner of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , director & Chief Executive Officer Jeremy Bender , and Chief Medical Officer Samuel C. Blackman .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Canaan Xi L.p. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 116,607 shares made by Samuel C. Blackman , a net sale of 150,568 shares made by Jeremy Bender , and a net sale of 106,697 shares made by York Charles N Ii .
In summary, during the past 3 months, insiders sold 225,453 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 225,453 shares. During the past 18 months, 471,785 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,772,899 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Canaan Xi L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Canaan Xi L.p.. You might contact Canaan Xi L.p. via mailing address: 2765 Sand Hill Rd, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
